Inhibrx Biosciences, Inc. — Institutional Ownership
Which tracked institutions hold INBX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
22
Funds holding
$531857110
Total value held
Buying
18 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $123937898 | 1308051 | +44973 | +3.56% |
| 2 | Sanofi | $109713489 | 1157926 | +1157926 | NEW BUY |
| 3 | Bank Of America Corp /De/ | $79698110 | 841141 | +808458 | +2473.63% |
| 4 | Blackrock, Inc. | $78260825 | 825972 | +27074 | +3.39% |
| 5 | State Street Corp | $60683396 | 640458 | +89613 | +16.27% |
| 6 | Goldman Sachs Group Inc | $38343051 | 404676 | +243102 | +150.46% |
| 7 | Northern Trust Corp | $9565676 | 100957 | +7261 | +7.75% |
| 8 | Citigroup Inc | $7174565 | 75721 | +19962 | +35.80% |
| 9 | Jefferies Financial Group Inc. | $6956166 | 73416 | +73416 | NEW BUY |
| 10 | Nomura Holdings Inc | $6954650 | 73400 | +57900 | +373.55% |
| 11 | Ubs Group Ag | $3318050 | 35019 | +35019 | NEW BUY |
| 12 | Bank Of New York Mellon Corp | $2482451 | 26200 | +326 | +1.26% |
| 13 | Invesco Ltd. | $1597295 | 16858 | +16858 | NEW BUY |
| 14 | Franklin Resources Inc | $1264249 | 13343 | -20864 | -60.99% |
| 15 | Wells Fargo & Company/Mn | $906094 | 9563 | +5625 | +142.84% |
| 16 | Jpmorgan Chase & Co | $502331 | 5260 | +328 | +6.65% |
| 17 | Janus Henderson Group Plc | $228684 | 3400 | +3400 | NEW BUY |
| 18 | Barclays Plc | $222380 | 2347 | +680 | +40.79% |
| 19 | Royal Bank Of Canada | $36000 | 386 | +279 | +260.75% |
| 20 | Us Bancorp \De\ | $5875 | 62 | -157 | -71.69% |
| 21 | Pnc Financial Services Group, Inc. | $3885 | 41 | — | Held |
| 22 | Fifth Third Bancorp | $1990 | 21 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.